arabinoxylan oligosaccharides
Botanicalexperimental
Clinical trial activity
7 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
2
Earliest trial started Oct 1, 2006 (NCT00853034)
Timeline
2010s
- Jan 1, 2011
Earliest Phase 2 Sponsor(trial)
Indications
Approved for
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- arabinoxylan oligosaccharides
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02922907 | N/A | Mar 24, 2017 | University of Southern California |
| NCT02623777 | N/A | Mar 1, 2015 | Katholieke Universiteit Leuven |
| NCT02141815 | Phase 2 | May 1, 2014 | Katholieke Universiteit Leuven |
| NCT02378376 | N/A | Jul 1, 2013 | Katholieke Universiteit Leuven |
| NCT01656499 | Phase 2 | Mar 1, 2011 | Katholieke Universiteit Leuven |
| NCT00852813 | Phase 4 | Oct 1, 2007 | Katholieke Universiteit Leuven |
| NCT00853034 | Phase 4 | Oct 1, 2006 | Katholieke Universiteit Leuven |
Showing 7 of 7 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Katholieke Universiteit Leuven | Academic/Hospital | 6 | 6 | 3 | 2006 |
| University of Southern California | Academic/Hospital | 1 | 1 | 1 | 2017 |
2 organizations
Page 1 / 1